Log In
Print
BCIQ
Print
Print this Print this
 

CVac

Also known as: Mannan/MUC-1 vaccine

  Manage Alerts
Collapse Summary General Information
Company Prima BioMed Ltd.
DescriptionEx vivo cancer vaccine using a patient's own dendritic cells primed with the tumor antigen mucin 1 (MUC1; CD227) and a mannan-fusion protein (M-FP)
Molecular Target Mucin 1 (MUC1) (CD227)
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today